Ameriprise Financial Inc Novavax Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Novavax Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 16,757 shares of NVAX stock, worth $132,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,757

Previous 28,774 41.76%

Holding current value

$132,883

Previous $364,000 42.03%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $128,702 - $205,610	-12,017 Reduced 41.76%	16,757 $211,000
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $13,089 - $70,564	-3,365 Reduced 10.47%	28,774 $364,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $120,842 - $193,476	32,139 New	32,139 $153,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $343,700 - $491,577	-50,470 Reduced 61.66%	31,386 $227,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $545,979 - $779,269	81,856 New	81,856 $608,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $256,266 - $724,256	28,924 New	28,924 $297,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $7.23 Million - $15 Million	199,244 Added 498.02%	239,251 $12.3 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $18 Million - $36.9 Million	-258,309 Reduced 86.59%	40,007 $2.94 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $26.2 Million - $42.4 Million	194,376 Added 187.01%	298,316 $42.5 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $95 Million - $145 Million	-534,148 Reduced 83.71%	103,940 $21.5 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $4.68 Million - $9.97 Million	38,678 Added 6.45%	638,088 $135 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $30.3 Million - $85.8 Million	-268,150 Reduced 30.91%	599,410 $109 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $19.9 Million - $35.3 Million	253,193 Added 41.21%	867,560 $96.7 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $44.9 Million - $101 Million	565,600 Added 1159.8%	614,367 $66.6 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $494,025 - $2.98 Million	35,644 Added 271.61%	48,767 $4.07 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $51,573 - $209,968	13,123 New	13,123 $178,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $620M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Novavax Inc Transaction History